r this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when sodium chloride injection, usp is administered to a nursing mother. pediatric use: safety and effectiveness in children have not been established. geriatric use: clinical studies of sodium chloride injection, usp did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. other reported clinical experience has not identified differences in responses between elderly and younger patients. in general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or drug therapy. this drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function. do not administer unless solution is clear and container is undamaged. discard unused portion.

r this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when sodium chloride injection, usp is administered to a nursing mother. pediatric use: safety and effectiveness in children have not been established. geriatric use: clinical studies of sodium chloride injection, usp did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. other reported clinical experience has not identified differences in responses between elderly and younger patients. in general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or drug therapy. this drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function. do not administer unless solution is clear and container is undamaged. discard unused portion.

y tissues and accounts for approximately 70% of total body weight. average normal adult daily requirements range from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production). water balance is maintained by various regulatory mechanisms. water distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (na + ) plays a major role in maintaining physiologic equilibrium.

on quality or safety. the opacity will diminish gradually. to assemble vial and flexible diluent container: (use aseptic technique) 1. remove the protective covers from the top of the vial and the vial port on the diluent container as follows: a. to remove the breakaway vial cap, swing the pull ring over the top of the vial and pull down far enough to start the opening (see figure 1), then pull straight up to remove the cap. (see figure 2.) note: once the breakaway cap has been removed, do not access vial with syringe. fig. 1 fig. 2 b. to remove the vial port cover, grasp the tab on the pull ring, pull up to break the three tie strings, then pull back to remove the cover. (see figure 3.) 2. screw the vial into the vial port until it will go no further. the vial must be screwed in tightly to assure a seal. this occurs approximately 1/2 turn (180°) after the first audible click. (see figure 4.) the clicking sound does not assure a seal; the vial must be turned as far as it will go. note: once vial is seated, do not attempt to remove. (see figure 4.) 3. recheck the vial to assure that it is tight by trying to turn it further in the direction of assembly. 4. label appropriately. fig. 3 fig. 4 to reconstitute the drug: 1. squeeze the bottom of the diluent container gently to inflate the portion of the container surrounding the end of the drug vial. 2. with the other hand, push the drug vial down into the container telescoping the walls of the container. grasp the inner cap of the vial through the walls of the container. (see figure 5.) 3. pull the inner cap from the drug vial. (see figure 6.) verify that the rubber stopper has been pulled out, allowing the drug and diluent to mix. 4. mix container contents thoroughly and use within the specified time. 5. look through the bottom of the vial to verify that the stopper has been removed and complete mixing has occurred. (see figure 7.) if the rubber stopper is not removed from the vial and medication is not released on the first attempt, the inner cap may be manipulated back into the rubber stopper without removing the drug vial from the diluent container. repeat steps 3 through 5. fig. 5 fig. 6 fig. 7 preparation for administration: (use aseptic technique) 1. confirm the activation and admixture of vial contents. 2. check for leaks by squeezing container firmly. if leaks are found, discard unit as sterility may be impaired. 3. close flow control clamp of administration set. 4. remove cover from outlet port at bottom of container. 5. insert piercing pin of administration set into port with a twisting motion until the pin is firmly seated. note: see full directions on administration set carton. 6. lift the free end of the hanger loop on the bottom of the vial, breaking the two tie strings. bend the loop outward to lock it in the upright position, then suspend container from hanger. 7. squeeze and release drip chamber to establish proper fluid level in chamber. 8. open flow control clamp and clear air from set. close clamp. 9. attach set to venipuncture device. if device is not indwelling, prime and make venipuncture. 10. regulate rate of administration with flow control clamp. warning: do not use flexible container in series connections. instructions for use with add-vantage addaptor ™ the instructions for use provided with the add-vantage addaptor™ should be made available to the individuals who perform the reconstitution steps. distributed by hospira, inc., lake forest, il 60045 usa lab-1103-2.0 revised: 11/2018 figure 1 figure 2 figure 3 figure 4 figure 5 figure 6 figure 7 hospira logo